Digi-Prex is a chronic disease management platform that provides a holistic solution to assist in the care of patients with chronic diseases.
Digi-Prex provides patients with access to discounted medicines that are delivered straight to the patient's home for no additional cost.
Digi-Prex was founded in 2019 by Samarth Sindhi. The company has its Indian headquartered located in Hyderabad, Telengana, India, with US headquarter based in San Francisco, California.
Digi-Prex is a seven-month old startup that runs an eponymous online subscription pharmacy in Hyderabad and serves patients with chronic diseases.
Digi-Prex works directly with medicine distributors to secure supplies at lower costs. It then undercuts the pricing of over-the-top counters, providing medicines to its customers at discounted rates.
Digi-Prex is backed by investors including Khosla Ventures, Vedanta Capital, Y Combinator, Quiet Capital, and SV Angel among others. The company raised $5.5M from a latest "Series A" financing on Sep 20, 2019. The round brings Digi-Prex's total funding to $5.7M to date.